CancerVax

About

No description available.

Ad copy example

CancerVax is developing a next-generation cancer immunotherapy platform designed to help the immune system recognize and destroy cancer cells. The technology combines targeted nanoparticle delivery with Smart mRNA that is designed to activate inside cancer cells while remaining deactivated in healthy cells. CancerVax is currently raising on StartEngine, where both accredited and non-accredited investors can invest. Explore the strategy, research progress, and investment opportunity in the Investor Brief.